Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-05-01 | ANI PHARMACEUTICALS INC | Gassert Chad
(SVP - CORP. DEV. & STRATEGY) |
S | Common Stock | D | 20000 | $66.62 - $66.62 | $1,332,400 |
| 2024-04-18 | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy
(HEAD OF R&D, COO-NOVITIUM OPS) |
S | Common Stock | D | 27232 | $64.98 - $65.17 | $1,772,728 |
| 2024-04-15 | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy
(HEAD OF R&D, COO-NOVITIUM OPS) |
S | Common Stock | D | 22768 | $65.40 - $66.33 | $1,500,588 |
| 2024-04-12 | ANI PHARMACEUTICALS INC | Cook Meredith
(SR. VP, GENERAL COUNSEL & SEC.) |
S | Common Stock | D | 250 | $67.79 - $67.79 | $16,947 |
| 2024-04-10 | ANI PHARMACEUTICALS INC | Marken James G.
(SVP OPS & PROD DEV) |
F | Common Stock | D | 2799 | $66.96 - $66.96 | $187,421 |
| 2024-04-10 | ANI PHARMACEUTICALS INC | CAREY STEPHEN P.
(SVP & CFO) |
F | Common Stock | D | 4534 | $66.96 - $66.96 | $303,596 |
| 2024-04-01 | ANI PHARMACEUTICALS INC | Gassert Chad
(SVP - CORP. DEV. & STRATEGY) |
S | Common Stock | D | 20000 | $67.25 - $67.25 | $1,345,000 |
| 2024-03-23 | ANI PHARMACEUTICALS INC | CAREY STEPHEN P.
(SVP & CFO) |
F | Common Stock | D | 6210 | $69.58 - $69.58 | $432,091 |
| 2024-03-13 | ANI PHARMACEUTICALS INC | Cook Meredith
(SR. VP, GENERAL COUNSEL & SEC.) |
S | Common Stock | D | 250 | $66.54 - $66.54 | $16,635 |
| 2024-03-08 | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy
(HEAD OF R&D, COO-NOVITIUM OPS) |
S | Common Stock | D | 10000 | $67.17 - $67.17 | $671,700 |
| 2024-03-11 | ANI PHARMACEUTICALS INC | CAREY STEPHEN P.
(SVP & CFO) |
S | Common Stock | D | 7787 | $65.55 - $65.55 | $510,437 |
| 2024-03-07 | ANI PHARMACEUTICALS INC | CAREY STEPHEN P.
(SVP & CFO) |
F | Common Stock | D | 4216 | $66.71 - $66.71 | $281,249 |
| 2024-03-06 | ANI PHARMACEUTICALS INC | Lalwani Nikhil
(PRESIDENT & CEO) |
S | Common Stock | D | 45257 | $65.52 - $67.13 | $2,991,467 |
| 2024-03-07 | ANI PHARMACEUTICALS INC | Lalwani Nikhil
(PRESIDENT & CEO) |
F | Common Stock | D | 17060 | $66.71 - $66.71 | $1,138,072 |
| 2024-03-07 | ANI PHARMACEUTICALS INC | Marken James G.
(SVP OPS & PROD DEV) |
S | Common Stock | D | 24338 | $66.37 - $66.37 | $1,615,313 |
| 2024-03-07 | ANI PHARMACEUTICALS INC | Marken James G.
(SVP OPS & PROD DEV) |
F | Common Stock | D | 2034 | $66.71 - $66.71 | $135,688 |
| 2024-03-07 | ANI PHARMACEUTICALS INC | Gutwerg Ori
(SVP, GENERICS) |
F | Common Stock | D | 2494 | $66.71 - $66.71 | $166,374 |
| 2024-03-07 | ANI PHARMACEUTICALS INC | Mutz Christopher
(HEAD OF RARE DISEASE) |
F | Common Stock | D | 2110 | $66.71 - $66.71 | $140,758 |
| 2024-03-05 | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy
(HEAD OF R&D, COO-NOVITIUM OPS) |
S | Common Stock | D | 40000 | $65.35 - $66.35 | $2,630,862 |
| 2024-02-29 | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy
(HEAD OF R&D, COO-NOVITIUM OPS) |
F | Common Stock | D | 1122 | $67.67 - $67.67 | $75,925 |
| 2024-02-29 | ANI PHARMACEUTICALS INC | Marken James G.
(SVP OPS & PROD DEV) |
F | Common Stock | D | 1058 | $67.67 - $67.67 | $71,594 |
| 2024-02-29 | ANI PHARMACEUTICALS INC | Lalwani Nikhil
(PRESIDENT & CEO) |
F | Common Stock | D | 10014 | $67.67 - $67.67 | $677,647 |
| 2024-02-29 | ANI PHARMACEUTICALS INC | Cook Meredith
(SR. VP, GENERAL COUNSEL & SEC.) |
F | Common Stock | D | 1173 | $67.67 - $67.67 | $79,376 |
| 2024-02-29 | ANI PHARMACEUTICALS INC | CAREY STEPHEN P.
(SVP & CFO) |
F | Common Stock | D | 1914 | $67.67 - $67.67 | $129,520 |
| 2024-02-15 | ANI PHARMACEUTICALS INC | Gutwerg Ori
(SVP, GENERICS) |
F | Common Stock | D | 1244 | $57.55 - $57.55 | $71,592 |
| 2024-02-14 | ANI PHARMACEUTICALS INC | Lalwani Nikhil
(PRESIDENT & CEO) |
A | Common Stock | A | 134216 | $0.00 - $0.00 | $0 |
| 2024-02-14 | ANI PHARMACEUTICALS INC | Marken James G.
(SVP OPS & PROD DEV) |
A | Common Stock | A | 16776 | $0.00 - $0.00 | $0 |
| 2024-02-14 | ANI PHARMACEUTICALS INC | Gutwerg Ori
(SVP, GENERICS) |
A | Common Stock | A | 24605 | $0.00 - $0.00 | $0 |
| 2024-02-14 | ANI PHARMACEUTICALS INC | Cook Meredith
(SR. VP, GENERAL COUNSEL & SEC.) |
A | Common Stock | A | 24605 | $0.00 - $0.00 | $0 |
| 2024-02-14 | ANI PHARMACEUTICALS INC | CAREY STEPHEN P.
(SVP & CFO) |
A | Common Stock | A | 35790 | $0.00 - $0.00 | $0 |
| 2024-02-13 | ANI PHARMACEUTICALS INC | Cook Meredith
(SR. VP, GENERAL COUNSEL & SEC.) |
S | Common Stock | D | 250 | $56.04 - $56.04 | $14,010 |
| 2024-01-19 | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy
(HEAD OF R&D, COO-NOVITIUM OPS) |
S | Common Stock | D | 25216 | $55.57 - $56.44 | $1,416,465 |
| 2024-01-16 | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy
(HEAD OF R&D, COO-NOVITIUM OPS) |
S | Common Stock | D | 24784 | $55.11 - $55.63 | $1,370,305 |
| 2024-01-12 | ANI PHARMACEUTICALS INC | Cook Meredith
(SR. VP, GENERAL COUNSEL & SEC.) |
S | Common Stock | D | 250 | $56.43 - $56.43 | $14,107 |
| 2023-12-15 | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy
(HEAD OF R&D, COO-NOVITIUM OPS) |
S | Common Stock | D | 50000 | $52.44 - $52.65 | $2,627,249 |
| 2023-11-17 | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy
(HEAD OF R&D, COO-NOVITIUM OPS) |
S | Common Stock | D | 13000 | $51.00 - $51.00 | $663,000 |
| 2023-11-14 | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy
(HEAD OF R&D, COO-NOVITIUM OPS) |
S | Common Stock | D | 37000 | $51.66 - $53.64 | $1,961,146 |
| 2023-11-15 | ANI PHARMACEUTICALS INC | Davis Krista
(SVP, CHIEF HR OFFICER) |
S | Common Stock | D | 2622 | $53.81 - $53.81 | $141,089 |
| 2023-11-14 | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy
(HEAD OF R&D, COO-NOVITIUM OPS) |
S | Common Stock | D | 36190 | $51.66 - $53.64 | $1,918,079 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |